Alison Krauss & Union Station – Oh, Atlanta…FAIL!….OR, the Importance of Sound Checks…
Alison Krauss & Union Station – Oh, Atlanta…FAIL!….OR, The Importance of Sound Checks… – On July 28, 2007, at Chicago’s Toyota Park, Alison Krauss & Union Station. despite the sound engineer, performed “Oh. Atlanta for Eric Clapton Crossroads Guitar Festival. The 2007 Crossroads Guitar Festival was held at Toyota Park in Bridgeview, Illinois on July 28, 2007. Tickets were estimated as sold out for the 28000 capacity park in 22 minutes. A DVD of the concert was released on November 20, 2007. The festival benefits the Crossroads Centre founded by Eric Clapton, a drug treatment center located in Antigua. The concerts are also intended to be a showcase for a variety of guitarists. All were hand-picked by Eric Clapton himself, who addressed the 2007 audience, saying that each were some of the very best, and those who had earned his respect.
Phase III study data shows Novartis drug Jakavi reduces myelofibrosis disease …
Filed under: Drug Treatment Atlanta
In these studies, Jakavi (INC424, ruxolitinib) treatment resulted in sustained reductions in spleen size, a hallmark of myelofibrosis, while also improving quality of life and extending overall survival compared to placebo or the best available therapy …
Read more on pharmabiz.com
Ariad reports most patients cancer-free after 1 year in ponatinib study
Filed under: Drug Treatment Atlanta
An ongoing Phase 2 pivotal trial of a potential drug to treat certain types of leukemia which is being developed by Ariad Pharmaceuticals Inc. found a majority of the 444 patients enrolled are cancer-free after a year. An ongoing Phase 2 pivotal trial …
Read more on Bizjournals.com (blog)
Article > Gilead to buy YM for 0 million
Filed under: Drug Treatment Atlanta
The firm reported positive results from a Phase I/II trial of the drug as a treatment for MF at the just-ended American Society of Hematology meeting in Atlanta and Gilead says that pending completion of the acquisition, it intends to initiate a Phase …
Read more on PharmaTimes
New Oral Drug in Multiple Myeloma May Be 'Game Changer'
Filed under: Drug Treatment Atlanta
ATLANTA, Georgia — An investigational drug for multiple myeloma, the first oral proteasome inhibitor, has shown promising results in an early phase1/2 clinical trial and has progressed straight into phase 3 clinical trials. If all goes well …
Read more on Medscape